ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.18 +0.07 (+1.58%)
As of: Oct 2, 2026 · 1:03 PM EDT

ARS Pharmaceuticals (SPRY) Long-Term Investments (2021 - 2022)

Updated

ARS Pharmaceuticals' Long-Term Investments came in at $24.22 million for Q2 2022, down 44.9% from the prior quarter.

Analysis

ARS Pharmaceuticals (SPRY) Long-Term Investments (2021 - 2022) Analysis & Trends

At the end of FY2021, ARS Pharmaceuticals' Long-Term Investments was $64.78 million.

  • Business Quant data shows SPRY's Long-Term Investments at $43.97 million (Q1 2022), $64.78 million (Q4 2021) and $39.94 million (Q3 2021) in the three quarters before Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 ARS Pharmaceuticals 428.58 Mn 284.78 Mn 20.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 24.22 Mn
Mar 31, 2022 43.97 Mn
Dec 31, 2021 64.78 Mn
Sep 30, 2021 39.94 Mn
API Access

ARS Pharmaceuticals Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=SPRY&period=max&api_key=YOUR_API_KEY